Gotoh L - Search Results

1

Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2.

Matsufuji M, Osaka H, Gotoh L, Shimbo H, Takashima S, Inoue K. Matsufuji M, et al. Among authors: gotoh l. Pediatr Neurol. 2013 Dec;49(6):477-81. doi: 10.1016/j.pediatrneurol.2013.07.012. Epub 2013 Oct 1. Pediatr Neurol. 2013. PMID: 24095575

2

GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease.

Gotoh L, Inoue K, Helman G, Mora S, Maski K, Soul JS, Bloom M, Evans SH, Goto YI, Caldovic L, Hobson GM, Vanderver A. Gotoh L, et al. Mol Genet Metab. 2014 Mar;111(3):393-398. doi: 10.1016/j.ymgme.2013.12.001. Epub 2013 Dec 16. Mol Genet Metab. 2014. PMID: 24374284 Free PMC article.

3

Attenuation of endoplasmic reticulum stress in Pelizaeus-Merzbacher disease by an anti-malaria drug, chloroquine.

Morimura T, Numata Y, Nakamura S, Hirano E, Gotoh L, Goto YI, Urushitani M, Inoue K. Morimura T, et al. Among authors: gotoh l. Exp Biol Med (Maywood). 2014 Apr;239(4):489-501. doi: 10.1177/1535370213520108. Epub 2014 Feb 12. Exp Biol Med (Maywood). 2014. PMID: 24521562

4

Epidemiological, clinical, and genetic landscapes of hypomyelinating leukodystrophies.

Numata Y, Gotoh L, Iwaki A, Kurosawa K, Takanashi J, Deguchi K, Yamamoto T, Osaka H, Inoue K. Numata Y, et al. Among authors: gotoh l. J Neurol. 2014 Apr;261(4):752-8. doi: 10.1007/s00415-014-7263-5. Epub 2014 Feb 16. J Neurol. 2014. PMID: 24532200

5

Corrigendum to "GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease" [Mol. Genet. Metab. 111 (2014) 393-398].

Gotoh L, Inoue K, Helman G, Mora S, Maski K, Soul JS, Bloom M, Evans SH, Goto YI, Caldovic L, Hobson GM, Vanderver A. Gotoh L, et al. Mol Genet Metab. 2016 Nov;119(3):293. doi: 10.1016/j.ymgme.2016.06.011. Mol Genet Metab. 2016. PMID: 27780564 No abstract available.

6

The voltage-gated sodium channel activator veratrine induces anxiogenic-like behaviors in rats.

Saitoh A, Makino Y, Hashimoto T, Yamada M, Gotoh L, Sugiyama A, Ohashi M, Tsukagoshi M, Oka J, Yamada M. Saitoh A, et al. Among authors: gotoh l. Behav Brain Res. 2015 Oct 1;292:316-22. doi: 10.1016/j.bbr.2015.06.022. Epub 2015 Jun 19. Behav Brain Res. 2015. PMID: 26099814

7

A pilot study exploring the association of morphological changes with 5-HTTLPR polymorphism in OCD patients.

Honda S, Nakao T, Mitsuyasu H, Okada K, Gotoh L, Tomita M, Sanematsu H, Murayama K, Ikari K, Kuwano M, Yoshiura T, Kawasaki H, Kanba S. Honda S, et al. Among authors: gotoh l. Ann Gen Psychiatry. 2017 Jan 17;16:2. doi: 10.1186/s12991-017-0126-6. eCollection 2017. Ann Gen Psychiatry. 2017. PMID: 28203264 Free PMC article.

8

Effects of repeated treatment with a delta opioid receptor agonist KNT-127 on hyperemotionality in olfactory-bulbectomized rats.

Gotoh L, Saitoh A, Yamada M, Fujii H, Nagase H, Yamada M. Gotoh L, et al. Behav Brain Res. 2017 Apr 14;323:11-14. doi: 10.1016/j.bbr.2016.11.008. Epub 2016 Dec 1. Behav Brain Res. 2017. PMID: 27916688

9

Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia.

Gotoh L, Yamada M, Hattori K, Sasayama D, Noda T, Yoshida S, Kunugi H, Yamada M. Gotoh L, et al. Psychiatry Res. 2019 Mar;273:331-335. doi: 10.1016/j.psychres.2019.01.052. Epub 2019 Jan 15. Psychiatry Res. 2019. PMID: 30682553

10

Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder.

Gotoh L, Yamada M, Hattori K, Sasayama D, Noda T, Yoshida S, Kunugi H, Yamada M. Gotoh L, et al. Heliyon. 2019 May 16;5(5):e01699. doi: 10.1016/j.heliyon.2019.e01699. eCollection 2019 May. Heliyon. 2019. PMID: 31193411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters